This is a summary of recommendations and resources for COVID-19 therapeutics adapted from information provided by the California Department of Public Health (CDPH). Because COVID-19 therapeutics are a rapidly changing area of pandemic response, we encourage all providers to regularly check for updates on variant resistance, eligible populations, and treatment guidelines.
Available Outpatient Therapies at Each Disease Stage
Pre Exposure Prophylaxis
-
The FDA authorized Evusheld for the pre-exposure prophylaxis of COVID-19 in certain adults and pediatric individuals (12 years of age and older weighing at leastt 88 lbs or 40 kg)
ORAL ANTIVIRAL TREATMENTS OUTPATIENT TREATMENT OPTIONS FOR COVID-19:
The FDA authorized two oral antivirals, Pfizer's Paxlovid and Merck's molnupiravir, for the treatment of COVID-19 in certain patients.
-
These medicines are only available by prescription from healthcare providers, including pharmacists.
-
Ask your provider if you are eligible for treatment. If they give you a prescription, click here, enter your address or zip code, and click on the box “Locations to fill a prescription.”
-
If you don’t have a doctor or can't get an appointment with your doctor or pharmacist, you can get testing and evaluation for treatment through either:
-
A Test to Treat site – click here, enter your address or zip code, and click on the box “Locations with testing, medical visits, and medication (Test-to-Treat)
-
California Department of Public Health’s FREE telehealth service – click here to access a virtual visit with a provider
-
Monoclonal Antibody Treatments
COVID-19 monoclonal antibody therapeutics (mAb) are available for people ages 12 years or older who:
-
Have tested positive for COVID-19 and have had symptoms for 10 days or less
-
Are at high risk of becoming seriously ill, including those who have been recently exposed to someone who tested positive for COVID-19.
- Discuss this option with your doctor.
BEST RESOURCES FOR UP-TO-DATE INFORMATION AND LOCATIONS:
-
NIH Treatment Guidelines: COVID-19 Treatment Guidelines (nih.gov)
-
Side-by-side comparison table for specific drugs: Side-by-Side Overview of Outpatient Therapies Authorized for Treatment of Mild-Moderate COVID-19 (hhs.gov)
- COVID-19 Treatment Resources for Healthcare Providers
HEALTHCARE PROVIDER FACT SHEETS:
-
Pre exposure: Evusheld
-
Post exposure:Paxlovid, Sotrovimab, Bebtelovimab, Remdesivir (here for patients <12 years of age), Molnupiravir,
-
Due to increases in Omicron BA.2 sub-variant in California, the FDA updated the sotrovimab EUA on 3/30/2022 and the drug is no longer authorized for use in California.
If you have additional questions, please email covid19vaccine@longbeach.gov or call 562.570.INFO.
Directory of Services
COVID-19 Hotline
Facilities
Main Health Facilities Center
2525 Grand Avenue
Long Beach, CA 90815
Phone: (562) 570-4000
Multi-Service Center for the Homeless »
1301 West 12th Street
Long Beach, CA 90813
Phone: (562) 570-4500
Fax: (562) 570-8234
North Facilities Center - Center for Family and Youth »
6335 Myrtle Avenue
Long Beach, CA 90805
Phone: (562) 570-3300
Fax: (562) 570-3306
Other Facilities »
